Business Description
BlossomHill Therapeutics is a San Diego-based drug development company founded in 2020, focused on creating new treatments for cancer patients with limited options. The company is currently testing three experimental drugs in clinical trials targeting lung cancer, acute myeloid leukemia, and a related blood disorder called myelodysplastic syndrome. Each drug is designed to block specific proteins that drive the growth of these cancers.
